CorTechs Labs Announces Official Support of Nuance PowerScribe 360 in NeuroQuant®
San Diego, CA (PRWEB) November 30, 2015 -- CorTechs Labs, the leading medical software innovator providing solutions for quantitative brain volume analysis, is pleased to announce that NeuroQuant now supports Nuance PowerScribe ® 360, a technology collaboration will support accurate and automatic field population of PowerScribe 360 reports with NeuroQuant’s volumetric MRI data.
Hospitals, clinics, imaging and research centers worldwide will benefit from this expanded capability, which provides automatic and flexible data integration of NeuroQuant’s 3D T1 MRI brain structure measurements, with Nuance PowerScribe 360, the industry’s most trusted and widely used real-time radiology reporting solution.
“We are excited to work with Nuance to provide our customers with streamlined reporting of NeuroQuant data through PowerScribe 360,” said Guri Stark, CorTechs Labs’ CEO. “We believe this collaboration will significantly benefit many physicians and clinicians using NeuroQuant in increasing productivity and reducing transcription and data entry errors, allowing them to deliver better patient care.”
For more information about using PowerScribe with NeuroQuant, please visit CorTechs Labs at Booth 1861 (Hall A, South) during Radiological Society of North America’s (RSNA) 2015 Annual Meeting (Nov. 29 – Dec. 4, McCormick Place, Chicago).
About CorTechs Labs
CorTechs Labs develops and markets cutting-edge brain imaging solutions used by neurologists and radiologists in hundreds of clinics and research centers around the world. CorTechs' flagship product, NeuroQuant®, is a breakthrough, 510(k) cleared software medical device that makes quantitative analysis of MRI images of the human brain a routine part of clinical practice. As the first FDA cleared and CE marked medical device capable of automatically detecting and quantifying atrophy in the human brain, NeuroQuant brings sophisticated, accurate, and fully automated MRI post-processing capabilities to the physician's desktop or mobile device. This provides neurologists, radiologists, and clinical researchers with a convenient and cost-effective means to quantify atrophy of brain structures to help diagnose a variety of brain disorders, including conditions such as Alzheimer's disease, epilepsy, multiple sclerosis and traumatic brain injury. Please visit http://www.cortechslabs.com for further information.
Stephanie Harrison, CorTechs Labs, Inc., http://www.cortechslabs.com, +1 (858) 459-9700, [email protected]
Share this article